ECT anesthesia showdown: does ketamine outperform propofol for severe depression?
NCT ID NCT07463911
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study observes 65 adults with major depression or bipolar depression who are receiving electroconvulsive therapy (ECT) as part of their routine care. Researchers track how two different anesthetics—ketamine plus propofol versus propofol alone—affect depression severity, suicidal thoughts, and dissociative symptoms over the course of ECT. The goal is to see if ketamine offers faster mood improvement without causing troubling side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR AFFECTIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pamukkale University
Denizli, 20570, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain wave clues: could inflammation markers forecast ECT outcomes?
- Brain scans may guide psychedelics and magnetic pulses to quell suicidal thoughts
- Brain wave patterns and inflammation: a clue to ECT's effectiveness in older adults?
- A headset for depression in pregnancy — science tests a Drug-Free option
- Can a common supplement lift depression and sharpen memory in seniors?
- Can pulling an all-nighter reveal how depression hijacks sleep and mood?